Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients

scientific article

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007126387
P356DOI10.1186/1479-5876-10-94
P932PMC publication ID3481359
P698PubMed publication ID22591651
P5875ResearchGate publication ID224970995

P50authorCarlo TortiQ30650659
Eugenia Quiros-RoldanQ30650722
Federico SeranaQ40533106
Luigi CaimiQ42806355
Marco ChiariniQ51012859
P2093author name stringAlessandra Sottini
Cinzia Zanotti
Luisa Imberti
Daria Gotti
P2860cites workLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7Q24673338
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasisQ28141430
Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsQ28146072
Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infectionQ28182419
Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) dataQ31105898
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapyQ34541705
Perturbations in B cell responsiveness to CD4 + T cell help in HIV-infected individualsQ35022773
Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearanceQ35230199
Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.Q35370381
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanismsQ35540019
Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccinesQ35696885
Identification and characterization of circulating human transitional B cellsQ35847513
Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansionQ36267196
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsQ36742299
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individualsQ36851936
Determination of thymic function directly from peripheral blood: a validated modification to an established method.Q36995849
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infectionQ37262403
B-cell activation and HIV-1 infection: deeds and misdeedsQ37805292
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretroviralsQ39530488
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).Q39530590
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapyQ39835442
The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiencyQ42833078
Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral bloodQ42944731
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.Q43223358
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialQ43265110
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapyQ44953874
Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.Q45372767
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 TrialQ45731634
Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virusQ45737589
Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infectionQ45761067
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturityQ45839362
IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activationQ46610378
Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patientsQ47958483
Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological agingQ49167316
Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis.Q52018556
Loss of memory (CD27) B lymphocytes in HIV-1 infection.Q52019275
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients.Q54702407
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitnessQ58276417
Changes in thymic function with age and during the treatment of HIV infectionQ59066353
Mechanisms Involved in the Low‐Level Regeneration of CD4+Cells in HIV‐1–Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral LoadsQ61565774
Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeQ72790552
Deleterious effect of HIV-1 plasma viremia on B cell costimulatory functionQ73496374
De novo T-cell generation in patients at different ages and stages of HIV-1 diseaseQ79859380
CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART)Q82599316
Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantationQ84188301
P921main subjectanti-retroviral agentQ50430310
P304page(s)94
P577publication date2012-05-16
P1433published inJournal of Translational MedicineQ15716664
P1476titleEffects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients
P478volume10

Reverse Query: null

Search more.